TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia

Norafiza Zainuddin, Fiona Murray, Meena Kanduri, Rebeqa Gunnarsson, Karin E. Smedby, Gunilla Enblad, Jesper Jurlander, Gunnar Juliusson, Richard Rosenquist

Research output: Contribution to journalArticlepeer-review

252 Downloads (Pure)

Abstract

TP53 mutations in the absence of 17p-deletion correlate with rapid disease progression and poor survival in chronic lymphocytic leukemia (CLL). Herein, we determined the TP53 mutation frequency in 268 newly diagnosed CLL patients from a population-based material. Overall, we detected TP53 mutations in 3.7% of patients (n = 10), where 7/10 cases showed a concomitant 17p-deletion, confirming the high prevalence of TP53 mutation in 17p-deleted patients. Only 3 (1.1%) of the newly diagnosed patients in our cohort thereby carried TP53 mutations without 17p-deletion, a frequency that is much lower than previous reports on referral cohorts (3-6%). Our findings imply that TP53 mutations are rare at CLL onset and instead may arise during disease progression. (C) 2010 Elsevier Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)272-274
JournalLeukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis
Volume35
Issue number2
DOIs
Publication statusPublished - 2011

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Hematology/Transplantation (013022014)

Subject classification (UKÄ)

  • Cancer and Oncology

Free keywords

  • TP53 mutation
  • 17p-deletion
  • Prognosis
  • Chronic lymphocytic leukemia

Fingerprint

Dive into the research topics of 'TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Cite this